| __timestamp | Grifols, S.A. | Travere Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 180753000 | 47795223 |
| Thursday, January 1, 2015 | 224193000 | 50426000 |
| Friday, January 1, 2016 | 197617000 | 70853000 |
| Sunday, January 1, 2017 | 288320000 | 78168000 |
| Monday, January 1, 2018 | 240661000 | 123757000 |
| Tuesday, January 1, 2019 | 276018000 | 140963000 |
| Wednesday, January 1, 2020 | 294216000 | 131773000 |
| Friday, January 1, 2021 | 354881000 | 210328000 |
| Saturday, January 1, 2022 | 361140000 | 235780000 |
| Sunday, January 1, 2023 | 330551000 | 244990000 |
Unleashing insights
In the competitive world of biopharmaceuticals, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Grifols, S.A. and Travere Therapeutics, Inc. have demonstrated contrasting strategies in their R&D investments.
Grifols, S.A., a global leader in plasma-derived medicines, has consistently increased its R&D budget, peaking in 2022 with a 100% increase from 2014. This steady growth underscores Grifols' dedication to advancing its product pipeline and maintaining its market leadership.
Conversely, Travere Therapeutics, Inc., a company focused on rare diseases, has shown a more volatile R&D spending pattern. Despite fluctuations, Travere's R&D expenses surged by over 400% from 2014 to 2023, reflecting its aggressive pursuit of breakthrough therapies.
These trends highlight the diverse approaches within the industry, where both stability and bold investment can drive innovation.
Who Prioritizes Innovation? R&D Spending Compared for Zoetis Inc. and Grifols, S.A.
Takeda Pharmaceutical Company Limited or Grifols, S.A.: Who Invests More in Innovation?
R&D Spending Showdown: Genmab A/S vs Travere Therapeutics, Inc.
R&D Spending Showdown: Grifols, S.A. vs Veracyte, Inc.
Grifols, S.A. vs MannKind Corporation: Strategic Focus on R&D Spending
R&D Insights: How Grifols, S.A. and BioCryst Pharmaceuticals, Inc. Allocate Funds
Who Prioritizes Innovation? R&D Spending Compared for Ionis Pharmaceuticals, Inc. and Travere Therapeutics, Inc.
Research and Development Investment: Viking Therapeutics, Inc. vs Travere Therapeutics, Inc.
Research and Development Expenses Breakdown: Xenon Pharmaceuticals Inc. vs Travere Therapeutics, Inc.
Research and Development Expenses Breakdown: Arrowhead Pharmaceuticals, Inc. vs Travere Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Travere Therapeutics, Inc. and Viridian Therapeutics, Inc.
R&D Insights: How Travere Therapeutics, Inc. and MiMedx Group, Inc. Allocate Funds